Homeopathic Treatment of Children Suffering From PFAPA
HOMPFAPA
1 other identifier
observational
13
1 country
1
Brief Summary
Periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome is frequently diagnosed in young children. Fevers recurring at a nearly predictable rate every three to eight weeks are the signature symptom of PFAPA syndrome. PFAPA is an acquired autoinflammatory disorder, which recurs in association with at least one sign of aphthous stomatitis, pharyngitis, and cervical lymph node enlargement. The aim of this retrospective case report is to gain an impression of the course of disease during individualized homeopathic treatment in children suffering from PFAPA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 8, 2023
CompletedFirst Submitted
Initial submission to the registry
August 9, 2023
CompletedFirst Posted
Study publicly available on registry
August 16, 2023
CompletedAugust 18, 2023
August 1, 2023
1.7 years
August 9, 2023
August 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Periodic fever flares
Appearance of periodic fever flares
30 months
Study Arms (1)
Children suffering from PFAPA
Children suffering from periodic fever, with at least one of the following symptoms: aphthous stomatitis, pharyngitis, cervical adenitis
Interventions
Homeopathic globules were administered after careful anamnesis
Eligibility Criteria
Children were suffering from PFAPA for at least 6 months.
You may qualify if:
- Children suffering from fever with at least one of the symptooms of PFAPA besides fever
You may not qualify if:
- Parents not willing to sign informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Michael Frasslead
Study Sites (1)
Michael Frass
Vienna, 1100, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Peter Panhofer, MD
Sigmund Freud Private University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
August 9, 2023
First Posted
August 16, 2023
Study Start
May 1, 2019
Primary Completion
December 31, 2020
Study Completion
August 8, 2023
Last Updated
August 18, 2023
Record last verified: 2023-08